title: [What is the clinical practice of partial nephrectomy in France?].
abstract: OBJECTIVE
  To describe the practice of partial nephrectomy (PN) in France and assess its results in terms of morbidity and cancer control.
  
  
  METHODS
  Seven French University Hospitals in which nephron sparing surgery represents at least 30% of the total number of nephrectomies for renal tumour, participated in this study. All centres included, as exhaustively as possible, all their PN cases. For each patient, 70 variables were harvested in order to characterize the patient population, the indications, the operative technique, the per- and postoperative course and complications, the tumor specificities, the carcinologic control and renal function follow-up.
  
  
  RESULTS
  Seven hundred and forty-one PN, of which 579 for malignant tumours were analysed. The mean tumour size was 3.4+/-2.1 cm (0.1-18) and 20.8% of the tumours were larger than 4 cm. In 30.1% of cases, the indication was imperative. Among the PN, 12.2% were performed laparoscopically. The mean operating time was 151+/-54.2 min (55-420). The medical and surgical complications rates were respectively 15.2 and 14.7%. At a mean 38 months follow-up, the local recurrence rate was 3.5% and the specific death rate was 4.5%.
  
  
  CONCLUSIONS
  PN is nowadays getting a more and more widely used technique in France. This expansion is completely justified by its results and urologists must consider nephron sparing surgery as the gold standard treatment for renal tumours measuring less than 4 cm.
authors.affiliation: Service d'Urologie et Transplantation Rénale, CHU de Bordeaux, Place Amélie-Raba-Léon, Bordeaux Cedex, France. jcb31000@hotmail.com <jcb31000@hotmail.com>
authors.forename: J-C
authors.initials: JC
authors.lastname: Bernhard
authors.forename: J-M
authors.initials: JM
authors.lastname: Ferriere
authors.forename: M
authors.initials: M
authors.lastname: Crepel
authors.forename: H
authors.initials: H
authors.lastname: Wallerand
authors.forename: L
authors.initials: L
authors.lastname: Bellec
authors.forename: B
authors.initials: B
authors.lastname: Lacroix
authors.forename: D
authors.initials: D
authors.lastname: Lopes
authors.forename: B
authors.initials: B
authors.lastname: Albouy
authors.forename: G
authors.initials: G
authors.lastname: Robert
authors.forename: A
authors.initials: A
authors.lastname: Ravaud
authors.forename: M
authors.initials: M
authors.lastname: Colombel
authors.forename: J
authors.initials: J
authors.lastname: Tostain
authors.forename: C
authors.initials: C
authors.lastname: Pfister
authors.forename: M
authors.initials: M
authors.lastname: Soulie
authors.forename: L
authors.initials: L
authors.lastname: Salomon
authors.forename: A
authors.initials: A
authors.lastname: De La Taille
authors.forename: G
authors.initials: G
authors.lastname: Pasticier
authors.forename: C C
authors.initials: CC
authors.lastname: Abbou
authors.forename: A
authors.initials: A
authors.lastname: Manunta
authors.forename: F
authors.initials: F
authors.lastname: Guille
authors.forename: J-J
authors.initials: JJ
authors.lastname: Patard
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016009:Chi-Square Distribution; D003627:Data Interpretation, Statistical; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006785:Hospitals, University; D006801:Humans; D007668:Kidney / Q000473:pathology; D007680:Kidney Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D009392:Nephrectomy / Q000379:methods*; D009399:Nephrons / Q000601:surgery; D018579:Patient Selection; D011183:Postoperative Complications; D010818:Practice Patterns, Physicians'; D012189:Retrospective Studies; D013997:Time Factors